Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2012
Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patientLaurent Suissa, Saskia Bresch, Sylvain Lachaud, et al.Journal of Neurology|June 5, 2024
Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravisCharlotte Héraud, Saskia Bresch, Cassandre Landes-Château, et al.Journal of Neuroimmunology|September 10, 2016
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravisChristine Lebrun, Véronique Bourg, Saskia Bresch, et al.Frontiers in Immunology|April 11, 2022
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter HyperintensitiesMichael Levraut, Cassandre Landes, Lydiane Mondot, et al.Neurology and Therapy|June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum DisordersChristine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2023
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated SyndromesMichael Levraut, Antoine Gavoille, Cassandre Landes-Chateau, et al.Multiple Sclerosis and Related Disorders|July 18, 2021
Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliabilityMikael Cohen, Saskia Bresch, Océane Thommel Rocchi, et al.Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.Multiple Sclerosis and Related Disorders|June 9, 2022
Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation studyMikael Cohen, Solange Hesse, Kevin Polet, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.Pageof 2